Danish Breast Cancer Cooperative Group - DBCG: History, organization, and status of scientific achievements at 30-year anniversary

Acta Oncologica

Volumn 47, Issue 4, 2008, Pages 497-505

  Blichert Toft, Mogens ^a   Christiansen, Peer ^a   Mouridsen, Henning T ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL STUDY; COHORT ANALYSIS; DATA BASE; GENETIC PREDISPOSITION; HEALTH CARE PERSONNEL; HEALTH PROGRAM; INFORMATION PROCESSING; MEDICAL SOCIETY; ONCOLOGY; PRIORITY JOURNAL; REVIEW; STANDARDIZATION; ARTICLE; BREAST TUMOR; DENMARK; FEMALE; HISTORY; HUMAN; ORGANIZATION AND MANAGEMENT;

ANNIVERSARIES AND SPECIAL EVENTS; BREAST NEOPLASMS; DENMARK; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MEDICAL ONCOLOGY; SOCIETIES, MEDICAL;

EID: 45149118046     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860802068615     Document Type: Review

References (25)

1. Fischerman K, Mouridsen HT. Danish Breast Cancer Cooperative Group - DBCG. Ugeskr Læger 1977;139:2493-4.
2. Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, et al. Relative survival of cancer patients. A comparison between Denmark and the other Nordic countries. Acta Oncol 1998;37:49-59.
3. Andreasen AH, Mouridsen HT, Andersen KW, Lynge E, Mouridsen M, Olesen KP. Prognoseforbedring for brystkræft. Ugeskr Læger 1994;156:6512-7.
4. Fisher B, Carbone P, Economu SG, Frelick R, Glass A, Lemer H, et al. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. N Engl J Med 1975;292:117-22.
5. Bonadonna G, Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405-10.
6. Danish Breast Cancer Cooperative Group. www.dbcg.dk
7. Møller S, Jensen M-B, Ejlertsen B, Bjerre KD, Larsen M, Hansen Hanne B, et al. The clinical database and the treatment guidelines programmes of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506-24.
8. EBCTCG, Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and on 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087-106.
9. EBCTCG, Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomized trials. Lancet 2005;365:1687-717.
10. Hermansen C, Poulsen SH, Jensen J, Langfeldt B, Steenskov V, Frederiksen P, et al. Diagnostic reliability of combined physical examination, mammography, and fine needle puncture ("Triple test") in breast tumours. Cancer 1987;60:1866-71.
11. Sundhedsstyrelsens udvalg vedr. "Brystkræft: Tidlig opsporing og undersøgelse". Sundhedsstyrelsen 1994.
12. Sundhedsstyrelsens notat vedr. "Vejledning om diagnostisk udredning af patienter med symptomer på eller hvor der er rejst mistanke om brystkræft". (2. rev. udg.). Sundhedsstyrelsen, 25 oktober, 1999.
13. Perry NM of behalf of the EUSOMA Working Party. Quality assurance in the diagnosis of breast disease. Eur J Cancer 2001;37:159-72.
14. Cady B. Total mastectomy and partial axillary dissection. Surg Clin North Am 1973;53:313-8.
15. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson C, Andersen KW, et al. Danish randomized trial comparing breast conservation with mastectomy: Six years of life-table analysis. J Natl Cancer Inst Monogr 1992;11:19-25.
16. Christiansen P, Friis E, Balslev E, Jensen D, Møller S. Sentinel node biopsy in breast cancer: Five years experience from Denmark. Acta Oncol 2008;47:561-68.
17. th ed. Brussels; European Commission: 2006. p 343-354.
18. Blichert-Toft M, Kroman N. The specialist breast unit and breast surgery as a specialty. Scand J Surgery 2002;91:227-31.
19. Cataliotti L, Wolf de C, Holland R, Marrotti L, Perry N, Redmond K, et al. EUSOMA guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer 2007;43:660-75.
20. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. for the Danish Breast Cancer Cooperative Group 82b Trial. Postoperative radiotherapy in high-risk pre-menopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;337:945-55.
21. Overgaard M, Jensen M-B, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999;353:1641-8.
22. Knoop AS, Knudsen H, Balslev E, Rasmussen BB, Overgaard J, Nielsen KV, et al. Retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to Cyclophosphamide, Methotrexate, and Fluorouracil or Cyclophosphamide, Epirubicin, and Fluorouracil: Danish Breast Cancer Cooperative Group. J Clin Oncol 2005;23:7483-90.
23. Grabau DAa, Jensen M-B, Blichert-Toft M, Andersen JA, Dyreborg U, Carstensen B, et al. The importance of surgery and accurate axillary staging for survival in breast cancer. Eur J Surg Oncol 1998;24:499-507.
24. Mouridsen HT, Bjerre KD, Christiansen P, Jensen M-B, Møller S. Improvement of prognosis in breast cancer in Denmark 1977-2006, based on the nationwide reporting to the DBCG registry. Acta Oncol 2008;47:525-36.
25. Andersen D. Læge og klinisk forsker (editorial). Ugeskr Læger 1991;153:2269.